Stockscreener 앱 받기
20.07
4.84%
-1.02
Tectonic Therapeutic Inc 주식(TECX)의 최신 뉴스
Form 4 Tectonic Therapeutic Inc: Marc Schwabish (Chief Business Officer) For: 25 September - Investing.com Nigeria
Form 4 Tectonic Therapeutic Inc: Alise Reicin (Director, CEO) For: 25 September - Investing.com Nigeria
Form 4 Tectonic Therapeutic Inc: Marc Schwabish (Chief Business Officer) For: 25 September - Investing.com UK
After 525 shares were withheld for taxes, Tectonic Therapeutic (TECX)'s medical chief holds 67,157 shares. - Stock Titan
An officer holds 44,903 shares after Tectonic Therapeutic (TECX) withholds 411 for taxes. - Stock Titan
After 520 shares were withheld for taxes, Tectonic Therapeutic (TECX) CFO holds 58,024 shares. - Stock Titan
493 shares are proposed for sale by officer Peter McNamara at Tectonic Therapeutic (TECX). - Stock Titan
Oppenheimer reiterates Tectonic Therapeutics stock rating on TX2100 data - Investing.com
A rare vascular disorder has no approved therapies. An experimental treatment was generally safe in healthy volunteers. - Stock Titan
Tectonic Therapeutic, Inc.Common Stock (NQ: TECX - The Chronicle-Journal
Tectonic Therapeutic (TECX) Clears Two Trial Hurdles With Cash To Spare - Yahoo Finance
Tectonic Therapeutic CFO Lochner Daniel Receives 24,250 Derivative Securities Award - Kalkine Media
Tectonic Therapeutic (TECX) ties CFO option grant to 42-month vesting schedule - Stock Titan
Tectonic Therapeutic (TECX) grants CEO 69,250 stock options with extended vesting - Stock Titan
Tectonic Therapeutic (TECX) awards CBO 17,750 stock options - Stock Titan
Tectonic Therapeutic (TECX) grants 24,250 options to its CMO - Stock Titan
Stock-option grant gives Tectonic Therapeutic (TECX) CSO 21,000 rights to buy shares - Stock Titan
Tectonic Therapeutic to Participate in the Morgan Stanley Global Healthcare Conference - GlobeNewswire
Tectonic Therapeutic advances TX45 trial with s... - pluang.com
Tectonic Therapeutic: Competitor Data Strengthens The TX45 Bull Case - Seeking Alpha
Tectonic Therapeutic Loses US$152m Market Value But Insiders See Windfall Of US$72k - simplywall.st
Tectonic (NASDAQ: TECX) ex-director lines up another stock sale - Stock Titan
Mizuho Securities Maintains Tectonic Therapeutic(TECX.US) With Buy Rating, Maintains Target Price $85 - Moomoo
Tectonic Therapeutic (NASDAQ: TECX) ex-director to sell 10,200 shares - Stock Titan
Tectonic Therapeutic (NASDAQ:TECX) Upgraded to "Hold" at Zacks Research - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Trading 5.6% HigherShould You Buy? - MarketBeat
TECX Q2 2026 Earnings: Narrower-than-Expected Loss Lifts Shares 2.74%Earnings Surprise Report - vinanet.vn
Tectonic Therapeutic CSO McNamara sells $1,505 in shares - Investing.com
Tectonic Therapeutic CSO McNamara sells $1,505 in shares By Investing.com - Investing.com India
Tectonic Therapeutic CSO McNamara sells $1,505 in shares By Investing.com - Investing.com UK
Tectonic Therapeutic CSO McNamara sells $1,505 in shares - Investing.com
TECX (TECX) insider plans 129-share sale and notes prior 10b5-1 trade - Stock Titan
Tectonic Therapeutic (NASDAQ:TECX) Trading Up 13.3%Here's What Happened - MarketBeat
Truist Financial Maintains Tectonic Therapeutic(TECX.US) With Buy Rating, Maintains Target Price $60 - Moomoo
Wells Fargo Maintains Tectonic Therapeutic(TECX.US) With Buy Rating, Cuts Target Price to $93 - Moomoo
Tectonic Therapeutic (NASDAQ:TECX) Upgraded by Wall Street Zen to "Sell" Rating - MarketBeat
Tectonic Therapeutic Inc (TECX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Tectonic Therapeutic (NASDAQ:TECX) Announces Earnings Results, Beats Estimates By $0.17 EPS - MarketBeat
TECX Maintained by Wells Fargo -- Price Target Lowered to $93.00 - GuruFocus
Piper Sandler Maintains Tectonic Therapeutic(TECX.US) With Buy Rating, Maintains Target Price $76 - Moomoo
Wells Fargo & Company Issues Pessimistic Forecast for Tectonic Therapeutic (NASDAQ:TECX) Stock Price - MarketBeat
Tectonic Therapeutic, Inc. (TECX) Investor Outlook: Exploring A 159.58% Potential Upside - DirectorsTalk Interviews
Tectonic Therapeutic, Inc. (NASDAQ:TECX) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
TECX Q1 2026 Earnings: Wider-than-Expected Loss as Clinical-Stage Pipeline Remains the FocusEarnings Revision Report - vinanet.vn
Tectonic Therapeutic, Inc. Stock 12‑Month Price Target Cut to $77.56, Implies 157% Upside - TradingView
Tectonic Therapeutic Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Tectonic Therapeutic, Inc. 2Q 2026: Net loss $22.3M, EPS $(1.18) — 10-Q Summary - TradingView
TECX: TX45 Phase 2 trial enrollment completed; topline results expected Q1 2027 - TradingView
Tectonic Therapeutic reports Q2 net loss $22.3M, cash $227.1M; TX45 enrollment complete - TradingView
Press Release: Tectonic Therapeutic Announces Second Quarter 2026 Financial Results and Recent Business Highlights - Moomoo
3.09%
0.72%
자본화:
|
볼륨(24시간):